Navigation Links
PTC Therapeutics Closes $50 Million Financing
Date:12/22/2009

SOUTH PLAINFIELD, N.J., Dec. 22 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the completion of a $50 million financing. The round was led by The Column Group - a new investor - and existing investor Delphi Ventures. The co-lead investors were joined by current investors Credit Suisse First Boston, HBM BioVentures, Novo A/S, Celgene, and other existing and new investors. In conjunction with the Delphi investment, general partner Deepa Pakianathan, Ph.D. will join PTC's Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

"We are delighted to welcome both The Column Group as an investor and Deepa as a Board member," stated Stuart W. Peltz, Ph.D., president and chief executive officer, PTC Therapeutics, Inc. "This is our first syndicated equity financing round in over four years, and serves as an important external validation of the tremendous progress we have made as a company since 2005, including advancing our lead product ataluren into multiple pivotal studies. We are grateful for the continued support from our existing investors."

"The Column Group focuses on companies with groundbreaking science, innovative products, and strong management talent. PTC epitomizes these attributes and we are pleased to lead this round," commented Rick Klausner, M.D., managing partner, The Column Group and former director of the National Cancer Institute. "With top line pivotal data for ataluren in DMD expected in 2010, we believe that PTC is on the cusp of significant value creation opportunities."

"As a long-term investor in PTC, we are delighted to co-lead this round and I am honored to join the PTC Board," added Deepa Pa
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fate Therapeutics iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs
2. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
3. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
4. Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 10, 2010
5. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
6. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
7. Oxygen Biotherapeutics, Inc. Expands Board of Directors
8. Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
9. Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market, Says Frost & Sullivan
10. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
11. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... LAKE CITY , Sept. 1, 2015 /PRNewswire/ ... that it will present at the First Annual ... in New York City.  Kelvyn H. Cullimore, ... present to leading institutional investment representatives on Tuesday, ... The Ladenburg Thalmann Conference will showcase leading-edge ...
(Date:9/1/2015)... VEGAS , Sept. 1, 2015  Dr. ... DigiPath Labs , the cannabis testing subsidiary of DigiPath, ... Patients Group about the lack of consistency in ... the online resource for medical cannabis information, she explained ... patients because their lack of uniform requirements makes standardization ...
(Date:9/1/2015)... , Sept. 1, 2015  Edwards Lifesciences Corporation ... science of heart valves and hemodynamic monitoring, is scheduled ... Conference at the Hyatt Regency Boston in ... Michael A. Mussallem , Edwards Lifesciences, ... speaker followed by a company discussion with conference attendees ...
Breaking Medicine Technology:DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3
... /PRNewswire/ -- Ethicon Endo-Surgery, Inc. today ... Digestive Disease Week (DDW) demonstrate the company,s novel, ... surgery (NOTES) procedures without laparoscopic support in porcine ... a new adaptable minimally-invasive surgical platform for NOTES ...
... Treatment Prediction Tool Wins Top Honors in Computerworld Honors Program ... IBM ) today announced it was selected for its contributions ... Computerworld Honors Program Laureate for 2009. , ... , , Developed by IBM researchers in Haifa, Israel, the ...
Cached Medicine Technology:Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox 2Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox 3Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox 4IBM and EU Partners Create a Better Way to Fight AIDS Virus 2IBM and EU Partners Create a Better Way to Fight AIDS Virus 3IBM and EU Partners Create a Better Way to Fight AIDS Virus 4
(Date:9/1/2015)... ... September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ...
(Date:9/1/2015)... Angeles, CA (PRWEB) , ... September 01, 2015 , ... ... American Medical Association, individuals with type 2 diabetes that participated in a three year ... diabetes three years down the line if they elected weight loss surgery at the ...
(Date:9/1/2015)... ... , ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive session of ... has taken place at Kingsborough Community College in Brooklyn in each of the past ... Calvary, and two junior counselors who were campers themselves just a few years ago. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer ... for Dermatologic Surgery, according to a new survey that also offers insight on ... Dermatologic Procedures – which reflects views on cosmetic medical treatments and ratings for ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, TX ... , an innovative vaginal health laser procedure that prevents and resolves dryness in ... atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse and ...
Breaking Medicine News(10 mins):Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3
... , TUESDAY, May 15 (HealthDay News) -- Black ... develop precancerous colorectal polyps, a new study finds. Researchers ... 50 and older who had a first-time colonoscopy screening at ... between 2006 and 2010. None of the patients had signs ...
... May 15 (HealthDay News) -- Researchers are preparing to test ... disease. The best-scenario hope is that the drug will ... and to a better understanding of its destructive processes, U.S. ... some Americans as well as 300 members of an extended ...
... TUESDAY, May 15 (HealthDay News) -- The lives of more ... 2004 and 2008 by the U.S. President,s Emergency Plan for ... adults, risk of death from all causes by 16 percent ... of Medicine researchers found. The researchers said this is the ...
... (HealthDay News) -- "Team-based care" should be used to ... on Community Preventive Services recommended on Tuesday. The ... that showed improvements in patients, control of blood pressure ... professionals -- a primary care doctor supported by a ...
... undergo radical surgery for prostate cancer may expect better ... hospitals with residency programs, and better still if the ... study by Henry Ford Hospital. The study, which ... throughout the U.S., also found that those with fewer ...
... Older, sicker, high-risk patients who undergo one of the ... in larger, busier hospitals, according to new research by ... research showed the experience level of the surgeon doing ... The results, based on data gathered throughout the ...
Cached Medicine News:Health News:Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought 2Health News:Trial Set to See if Drug Can Prevent Alzheimer's 2Health News:U.S. Task Force Issues Blood Pressure Guidelines 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2
Ergotec Vetriretinal Instrument System. 2 mm pointed tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Angled shafts with 12 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left. Most popular size or model....
Angled shafts with 9 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left....
Angled 13.5 mm adjustable blades. Teeth in lower jaws fit into holes in upper jaws. Grooves in lower jaw for passage of suture needles. Round knurled handle with polished finish....
Medicine Products: